SNO/NCI Joint Symposium: Targeting CNS Tumor Metabolism
Tuesday April 6, 2021 11:00 AM-4:35PM EST
Wednesday April 7, 2021 11:00 AM-2:40 PM EST
The SNO-NCI Joint Symposium: “Targeting CNS Tumor Metabolism” will foster collaboration in the area of metabolism which will positively influence outcomes for patients with CNS cancers. This is the first conference that focuses on the tumor metabolism and it is expected to be both didactic as well as a collegial learning environment with the goal to enhance partnerships and advance the treatment for patients. Metabolic investigations for these tumors have been conducted in isolation and the goal of this meeting is to bring together the clinicians with the experts in metabolism in order to increase the utilization of metabolic investigations in the clinical settings.
Participants will gain new understanding in CNS tumor metabolism via the use of state-of-the-art techniques; the interaction between the metabolism and the other -omics such as epigenomics, transcriptomics, as well as the current standard of care; and the challenges in targeting the metabolic signaling pathways.
Topics to be covered over this two-day event include:
- Epigenome, Transcriptome, Metabolome and Modeling
- Metabolic Fluxes and Signaling of Metabolic Pathways
- New Technologies for Studying Brain Metabolism
- Metabolic Biomarkers and Imaging
- Metabolic Drug Targets, Resistance
Paul Mischel, MD, Distinguished Professor, University of California San Diego
Craig Thompson, MD, President and CEO, Memorial Sloan Kettering Cancer Center
Daniel Cahill, MD, PhD, Harvard Medical School
Sabrina Ronen, PhD, University of California, San Francisco
Ovidiu Andronesi, MD, PhD, Harvard Medical School
Christian Metallo, PhD, University of California San Diego
Houtan Noushmehr, PhD, Henry Ford Cancer Institute
Scientific Program Committee
Mioara Larion, PhD, National Institutes of Health (NCI Program Co-Chair)
Elizabeth Maher, MD, PhD, UT Southwestern Medical Center (SNO Program Co-Chair)
Mark Gilbert, MD, National Institutes of Health (NCI Institutional Chair)
Gelareh Zadeh, MD, PhD, University of Toronto (SNO Institutional Chair)
Thanks to the generosity of the Dabbiere family, the entire SNO-NCI Joint Symposium: Targeting CNS Tumor Metabolism is being made available to the neuro-oncology community at no charge. To register, click here.